Supplementary Table S3 from MEN1309/OBT076, a First-In-Class Antibody–Drug Conjugate Targeting CD205 in Solid Tumors

Abstract

<p>Supplementary Table S3: Cross reactivity data obtained from whole blood of different species. Values are expressed as the concentration at which MBH1309/OBT076 has half-maximum binding [EC50].</p>